Cancers
Radiomics for Predicting the Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Radiomics Quality Score Assessment.
Ruixin Zhang, Chengjie Zhang, Yi Liu, Zhiguo Gui, Anhong Zhang
Published: 202610.3390/cancers18020186
Abstract
BACKGROUND/OBJECTIVES: Hepatocellular carcinoma (HCC) immunotherapy provides limited clinical benefits, partly due to the lack of reliable efficacy biomarkers. Radiomics, which non-invasively analyzes tumor heterogeneity, shows promising potential fo…
Preview only. Read the full abstract at the source